Chinese herbal medicine formula of gynecological gel

Abstract

The invention discloses a Chinese herbal medicine formula of gynecological gel. The formula comprises the following raw materials by weight ratio: 5 to 15g of Astragalus mongholicus, 2 to 11g of silkworm, 5 to 11g of fructus cnidii, 3 to 8g of Echinacea Extract, 3 to 11g of dandelion, 3 to 9g of propolis, 1 to 19g of globeflower, 8 to 20g of Rhodiola, 7 to 17g of radix sophorae flavescentis, 3 to 12g of realgar, 4 to 13g of saffron, 2 to 6g of Vitamin E, and 2 to 8g of borneol. On the condition of curing diseases, the formula does not damage genital tract environment, kill beneficial flora of human body, generate drug resistance and tolerance, and is not hazardous to human body. Besides, the formula is better and safer in use and can reduce harm brought by toxic or side effect of drugs to human body. By promoting the immune function of the body, the formula allows patients to avoid the toxic or side effect of drugs.

Description

technical field [0001] The invention relates to a medicine for treating gynecological diseases, more specifically, a Chinese herbal medicine formula of gynecological gel. Background technique [0002] The drugs used for gynecological inflammation on the market have the following problems: 1. Almost all the drugs for gynecological inflammation currently on the market will damage the reproductive tract environment and the self-secretion function of the mucous membrane, thereby leading to a decline in the reproductive local immunity and causing The pathogenic bacteria develop drug resistance and drug resistance, and eventually the inflammation recurs; 2. At present, most of the treatments for cervical erosion are physical and surgical methods, which are traumatic to the human body, and women who have undergone cervical surgery cannot give birth naturally. After surgery and physical therapy, the cervical secretion function is destroyed, and the vaginal resistance decreases, whic...

AI Technical Summary

Problems solved by technology

[0002] The drugs used for gynecological inflammation on the market have the following problems: 1. Almost all the drugs for gynecological inflammation currently on the market will damage the reproductive tract environment and the self-secretion function of the mucous membrane, thereby leading to a decline in the reproductive local immunity and causing The pathogenic bacteria develop drug resistance and drug resistance, and eventually the inflammation recurs; 2. At present, most of the treatments for cervical erosion are physical and surgical methods, which are traumatic to the human body, and women who have undergone cervical surgery cannot give birth naturally. After surgery and physical therapy, the cervical secretion function is destroyed, and the vaginal resistance decreases, which seriously affects sexual life and reproductive health